Clinical Trial Update: Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating autologous transplant followed by allogeneic transplant for high-risk Neuroblastoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Columbia University | Conditions: Neuroblastoma | Phase 1 | Status: TERMINATED